Baby Brent’s Bill
The source supplies the latest action, but no lifecycle stage.
Latest action (27 Jul 2026): Referred to the House Committee on Energy and Commerce.
What this bill does
This bill, titled "Baby Brent's Bill," would direct the Federal Trade Commission (FTC) to investigate the advertising and marketing of preterm infant formula. The FTC would be required to identify any unfair or deceptive practices, specifically considering whether such materials omit information about potential health risks or differences between human milk-based and bovine-based fortifiers.
Following the investigation, the FTC would submit a report to Congress with its findings and recommendations. Within 18 months of this report, the FTC would then issue regulations to prohibit unfair or deceptive acts or practices in the advertising and marketing of preterm infant formula, with enforcement handled under the Federal Trade Commission Act.
The bill affects manufacturers and importers of preterm infant formula. It also implicitly affects parents and guardians of preterm infants by aiming to ensure they receive complete information. The bill is in the "Introduced" status, meaning it has been formally presented to the House of Representatives and referred to the Committee on Energy and Commerce. No further action has been taken.
Plain-English summary generated by Bill100 AI from the official record. Always verify against the source below.
Timeline
27 Jul 2026
Referred to the House Committee on Energy and Commerce.
Common questions
- What does H.R. 9969 do?
- This bill, titled "Baby Brent's Bill," would direct the Federal Trade Commission (FTC) to investigate the advertising and marketing of preterm infant formula. The FTC would be required to identify any unfair or deceptive practices, specifically considering whether such materials omit information about potential health risks or differences between human milk-based and bovine-based fortifiers. Following the investigation, the FTC would submit a report to Congress with its findings and recommendations. Within 18 months of this report, the FTC would then issue regulations to prohibit unfair or deceptive acts or practices in the advertising and marketing of preterm infant formula, with enforcement handled under the Federal Trade Commission Act. The bill affects manufacturers and importers of preterm infant formula. It also implicitly affects parents and guardians of preterm infants by aiming to ensure they receive complete information. The bill is in the "Introduced" status, meaning it has been formally presented to the House of Representatives and referred to the Committee on Energy and Commerce. No further action has been taken.
- Has H.R. 9969 become law?
- The source does not supply a confirmed lifecycle stage for H.R. 9969. Check the latest action and official source below.
- Who sponsored H.R. 9969?
- H.R. 9969 was sponsored by Rep. Pappas, Chris [D-NH-1] (D-NH), with 2 cosponsors.
- What's the latest action on H.R. 9969?
- Referred to the House Committee on Energy and Commerce. (27 Jul 2026).
Related bills in Commerce
Critical Infrastructure Manufacturing Feasibility Act
Cybersecurity for Small Businesses Act of 2026
Ensuring SBA Implementation of GAO Recommendations Act of 2026
SCORE for Small Business Act of 2026
More bills from Rep. Pappas, Chris [D-NH-1]
Investing in State Energy Act of 2026
Turn the Tide Act
Apprenticeship Program National Scorecard Act
United States-Israel Health Technologies Cooperation Act
Bill100 mirrors the public U.S. legislative record from Congress.gov and GovTrack and adds plain-English AI summaries. It is an information tool, not legal, compliance or lobbying advice, and it is not affiliated with the U.S. Congress or any government agency. AI summaries can simplify or omit detail — every bill links to the official source; verify there before you rely on it.